{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T19:53:22Z","timestamp":1774036402388,"version":"3.50.1"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004728","name":"Vellore Institute of Technology","doi-asserted-by":"publisher","award":["SG20220091"],"award-info":[{"award-number":["SG20220091"]}],"id":[{"id":"10.13039\/501100004728","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computer Methods and Programs in Biomedicine"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.cmpb.2026.109293","type":"journal-article","created":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T23:06:01Z","timestamp":1771801561000},"page":"109293","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Explainable machine learning framework for the molecular classification of triple negative breast cancer"],"prefix":"10.1016","volume":"279","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6655-4450","authenticated-orcid":false,"given":"Biji C.","family":"L","sequence":"first","affiliation":[]},{"given":"Trupti","family":"Patel","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3887-3199","authenticated-orcid":false,"given":"Devyani","family":"Charan","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0143-645X","authenticated-orcid":false,"given":"Mangalam Goutam","family":"Sinha","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1126-6101","authenticated-orcid":false,"given":"Rupaak","family":"S","sequence":"additional","affiliation":[]},{"given":"Medhansh","family":"Jain","sequence":"additional","affiliation":[]},{"given":"Ashutosh","family":"Bhardwaj","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6049-1559","authenticated-orcid":false,"given":"Annanya","family":"Gupta","sequence":"additional","affiliation":[]},{"given":"Dheeba","family":"J","sequence":"additional","affiliation":[]},{"given":"Athira","family":"K","sequence":"additional","affiliation":[]},{"given":"Ankita","family":"Mishra","sequence":"additional","affiliation":[]},{"given":"Deepak","family":"Mishra","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/j.cmpb.2026.109293_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13058-020-01296-5","article-title":"Triple-negative breast cancer molecular subtyping and treatment progress","volume":"22","author":"Yin","year":"2020","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.cmpb.2026.109293_bib0002","doi-asserted-by":"crossref","DOI":"10.1177\/15330338221145246","article-title":"Molecular classification, treatment, and genetic biomarkers in triple-negative breast cancer: a review","volume":"22","author":"Lu","year":"2023","journal-title":"Technol. Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.cmpb.2026.109293_bib0003","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000455820","article-title":"Biological subtypes of triple-negative breast cancer","volume":"12","author":"Hubalek","year":"2017","journal-title":"Breast Care"},{"issue":"2","key":"10.1016\/j.cmpb.2026.109293_bib0004","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3390\/jpm11020061","article-title":"Breast cancer type classification using machine learning","volume":"11","author":"Wu","year":"2021","journal-title":"J. Pers. Med."},{"issue":"1","key":"10.1016\/j.cmpb.2026.109293_bib0005","doi-asserted-by":"crossref","first-page":"415","DOI":"10.11591\/ijai.v12.i1.pp415-421","article-title":"Comparison of machine learning models for breast cancer diagnosis","volume":"12","author":"Kadhim","year":"2023","journal-title":"IAES Int. J. Artif. Intell."},{"key":"10.1016\/j.cmpb.2026.109293_bib0006","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrclinonc.2016.66","article-title":"Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease","volume":"13","author":"Bianchini","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.cmpb.2026.109293_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101086","article-title":"Comparative analysis of triple-negative breast cancer transcriptomics of Kenyan, African American and Caucasian Women","volume":"14","author":"Saleh","year":"2021","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.cmpb.2026.109293_bib0008","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.681476","article-title":"Current triple-negative breast cancer subtypes: dissecting the most aggressive form of breast cancer","volume":"11","author":"Ensenyat-Mendez","year":"2021","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.cmpb.2026.109293_bib0009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157368","article-title":"Refinement of triple-negative breast cancer molecular subtypes: implications for neoadjuvant chemotherapy selection","volume":"11","author":"Lehmann","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.cmpb.2026.109293_bib0010","doi-asserted-by":"crossref","first-page":"9059","DOI":"10.2147\/OTT.S223603","article-title":"Supervised machine learning predictive analytics for triple-negative breast cancer death outcomes","author":"Xu","year":"2019","journal-title":"OncoTargets Ther."},{"issue":"8","key":"10.1016\/j.cmpb.2026.109293_bib0011","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.molmed.2024.04.017","article-title":"Copy number alterations: a catastrophic orchestration of the breast cancer genome","volume":"30","author":"Shahrouzi","year":"2024","journal-title":"Trends Mol. Med."},{"issue":"4","key":"10.1016\/j.cmpb.2026.109293_bib0012","doi-asserted-by":"crossref","first-page":"916","DOI":"10.3390\/cancers12040916","article-title":"The landscape of targeted therapies in TNBC","volume":"12","author":"Vagia","year":"2020","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.cmpb.2026.109293_bib0013","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s00438-022-01932-z","article-title":"Breast cancer stage prediction: a computational approach guided by transcriptome analysis","volume":"297","author":"Athira","year":"2022","journal-title":"Mol. Genet. Genom."},{"issue":"1","key":"10.1016\/j.cmpb.2026.109293_bib0014","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-67643-w","article-title":"Systems biology comprehensive analysis on breast cancer for identification of key gene modules and genes associated with TNM- based clinical stages","volume":"10","author":"Amjad","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cmpb.2026.109293_bib0015","article-title":"A machine learning model to predict the triple negative breast cancer immune subtype","volume":"12","author":"Chen","year":"2021","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.cmpb.2026.109293_bib0016","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3390\/jpm11090881","article-title":"Molecular classification models for triple negative breast cancer subtype using machine learning","volume":"11","author":"Bissanum","year":"2021","journal-title":"J. Pers. Med."},{"issue":"11","key":"10.1016\/j.cmpb.2026.109293_bib0017","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1007\/s11517-023-02892-1","article-title":"Enhancing the prediction of IDC breast cancer staging from gene expression profiles using hybrid feature selection methods and deep learning architecture","volume":"61","author":"Kishore","year":"2023","journal-title":"Med. Biol. Eng. Comput."},{"key":"10.1016\/j.cmpb.2026.109293_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.bspc.2023.104979","article-title":"XAI-CNVMarker: explainable AI-based copy number variant biomarker discovery for breast cancer subtypes","volume":"84","author":"Rajpal","year":"2023","journal-title":"Biomed. Signal Process. Control"},{"key":"10.1016\/j.cmpb.2026.109293_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.eswa.2023.120130","article-title":"XAI-MethylMarker: explainable AI approach for biomarker discovery for breast cancer subtype classification using methylation data","volume":"225","author":"Rajpal","year":"2023","journal-title":"Expert Syst. Appl."},{"issue":"5","key":"10.1016\/j.cmpb.2026.109293_bib0020","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/cac2.12530","article-title":"Discovering genetic biomarkers for targeted cancer therapeutics with explainable artificial intelligence","volume":"44","author":"Chakraborty","year":"2024","journal-title":"Cancer Commun."},{"key":"10.1016\/j.cmpb.2026.109293_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.eswa.2024.124239","article-title":"Discovering novel prognostic biomarkers of hepatocellular carcinoma using explainable artificial intelligence","volume":"252","author":"Gutierrez-Chakraborty","year":"2024","journal-title":"Expert Syst. Appl."},{"key":"10.1016\/j.cmpb.2026.109293_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2024.108844","article-title":"Exploring explainable AI features in the vocal biomarkers of lung disease","volume":"179","author":"Chen","year":"2024","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.cmpb.2026.109293_bib0023","article-title":"A machine learning model to predict the triple negative breast cancer immune subtype","volume":"12","author":"Chen","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cmpb.2026.109293_bib0024","article-title":"Machine learning model to predict the triple negative breast cancer immune subtype","volume":"12","author":"Chen","year":"2021","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.cmpb.2026.109293_bib0025","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.3390\/biom13081207","article-title":"Challenges and opportunities in developing targeted therapies for triple negative breast cancer","volume":"13","author":"Chapdelaine","year":"2023","journal-title":"Biomolecules"},{"issue":"9","key":"10.1016\/j.cmpb.2026.109293_bib0026","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.3390\/cancers12092392","article-title":"Perspectives on triple-negative breast cancer: current treatment strategies, unmet needs, and potential targets for future therapies","volume":"12","author":"Gupta","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.cmpb.2026.109293_bib0027","first-page":"1","article-title":"SMOTE for high-dimensional class-imbalanced data","volume":"14","author":"Blagus","year":"2013","journal-title":"BMC Bioinform."},{"key":"10.1016\/j.cmpb.2026.109293_bib0028","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.giec.2020.02.004","article-title":"Risk stratification strategies for colorectal cancer screening: from logistic regression to artificial intelligence","volume":"30","author":"Imperiale","year":"2020","journal-title":"Gastrointest. Endosc. Clin. N. Am."},{"key":"10.1016\/j.cmpb.2026.109293_bib0029","article-title":"Application of decision tree-based ensemble learning in the classification of breast cancer","volume":"28","author":"Ghiasi","year":"2021","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.cmpb.2026.109293_bib0030","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.procs.2023.01.025","article-title":"Diagnosis of breast cancer using random forests","volume":"218","author":"Minnoor","year":"2023","journal-title":"Procedia Comput. Sci."},{"issue":"8","key":"10.1016\/j.cmpb.2026.109293_bib0031","article-title":"Gradient boosting prediction of overlapping genes from weighted co-expression and differential gene expression analysis of Wnt pathway: an artificial intelligence-based bioinformatics study","volume":"16","author":"Yadalam","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.cmpb.2026.109293_bib0032","series-title":"Advanced Technologies, Systems, and Applications VIII. IAT 2023. Lecture Notes in Networks and Systems","article-title":"Breast cancer classification using support vector machines (SVM)","volume":"644","author":"Telalovi\u0107 Hasi\u0107","year":"2023"},{"key":"10.1016\/j.cmpb.2026.109293_bib0033","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.biosystems.2018.12.009","article-title":"Gene expression cancer classification using modified K-Nearest Neighbors technique","volume":"176","author":"Ayyad","year":"2019","journal-title":"Biosystems"},{"key":"10.1016\/j.cmpb.2026.109293_bib0034","series-title":"2019 International Engineering Conference (IEC)","first-page":"165","article-title":"Cancer classification using Gaussian naive Bayes algorithm","author":"Kamel","year":"2019"},{"issue":"1","key":"10.1016\/j.cmpb.2026.109293_bib0035","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3390\/medicina57010062","article-title":"Triple negative breast cancer: a review of present and future diagnostic modalities","volume":"57","author":"Dass","year":"2021","journal-title":"Medicina"},{"issue":"9","key":"10.1016\/j.cmpb.2026.109293_bib0036","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.21037\/tcr-22-662","article-title":"Integrated bioinformatic analysis of potential biomarkers of poor prognosis in triple-negative breast cancer","volume":"11","author":"Bissanum","year":"2022","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.cmpb.2026.109293_bib0037","unstructured":"Chen, S. (2021). Interpretation of multi-label classification models using shapley values. arXiv preprint arXiv:2104.10505. https:\/\/doi.org\/10.48550\/arXiv.2104.10505."},{"key":"10.1016\/j.cmpb.2026.109293_bib0038","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13578-025-01359-0","article-title":"Classifications of triple-negative breast cancer: insights and current therapeutic approaches","volume":"15","author":"Chen","year":"2025","journal-title":"Cell Biosci."},{"issue":"4","key":"10.1016\/j.cmpb.2026.109293_bib0039","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0231953","article-title":"Identification of triple-negative breast cancer cell lines classified under the same molecular subtype using different molecular characterization techniques: implications for translational research","volume":"15","author":"Espinosa Fernandez","year":"2020","journal-title":"PLOS One"},{"issue":"12","key":"10.1016\/j.cmpb.2026.109293_bib0040","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.7150\/jca.93215","article-title":"Comparative evaluation of machine learning models for subtyping triple-negative breast cancer: a deep learning-based multi-omics data integration approach","volume":"15","author":"Yang","year":"2024","journal-title":"J. Cancer"},{"issue":"4","key":"10.1016\/j.cmpb.2026.109293_bib0041","article-title":"DLX6: a novel immune-related prognostic biomarker for nasopharyngeal carcinoma","volume":"15","author":"Cai","year":"2023","journal-title":"Cureus J. Med. Sci."},{"key":"10.1016\/j.cmpb.2026.109293_bib0042","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.4928","article-title":"Crucial biological functions of CCL7 in cancer","volume":"6","author":"Liu","year":"2018","journal-title":"PeerJ"},{"key":"10.1016\/j.cmpb.2026.109293_bib0043","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.723477","article-title":"Identification of five cytotoxicity-related genes involved in the progression of triple- negative breast cancer","volume":"12","author":"Zhang","year":"2022","journal-title":"Front. Genet."},{"issue":"12","key":"10.1016\/j.cmpb.2026.109293_bib0044","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114900","article-title":"Mesothelin expression in triple negative breast carcinomas correlates significantly with basal-like phenotype, distant metastases and decreased survival","volume":"9","author":"Tozbikian","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.cmpb.2026.109293_bib0045","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.canlet.2021.04.028","article-title":"GABRP sustains the stemness of triple-negative breast cancer cells through EGFR signaling","volume":"514","author":"Li","year":"2021","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.cmpb.2026.109293_bib0046","doi-asserted-by":"crossref","first-page":"129","DOI":"10.7555\/JBR.34.20190111","article-title":"RNA-seq analysis identified hormone-related genes associated with prognosis of triple negative breast cancer","volume":"34","author":"Chen","year":"2020","journal-title":"J. Biomed. Res."},{"key":"10.1016\/j.cmpb.2026.109293_bib0047","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ebiom.2019.04.001","article-title":"Overexpression of PIMREG promotes breast cancer aggressiveness via constitutive activation of NF-\u03baB signaling","volume":"43","author":"Jiang","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.cmpb.2026.109293_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2019.06.001","article-title":"Role of fatty acid binding proteins (FABPs) in cancer development and progression","volume":"62","author":"McKillop","year":"2019","journal-title":"Cell. Signal."},{"key":"10.1016\/j.cmpb.2026.109293_bib0049","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.matbio.2015.01.013","article-title":"ADAMTS proteases and cancer","volume":"44","author":"Cal","year":"2015","journal-title":"Matrix Biol."},{"key":"10.1016\/j.cmpb.2026.109293_bib0050","series-title":"KR102237463B1 Use of LYPD1 For Cancer Diagnostic Or Therapeutic Marker - Google Patents","author":"Kim","year":"2014"},{"key":"10.1016\/j.cmpb.2026.109293_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122205","article-title":"Tumor microenvironment-initiated lipid redox cycling for efficient triple-negative breast cancer therapy","volume":"300","author":"Zhou","year":"2023","journal-title":"Biomaterials"},{"issue":"13","key":"10.1016\/j.cmpb.2026.109293_bib0052","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1111\/jcmm.17714","article-title":"The molecular and clinical role of tensin 1\/2\/3 in cancer","volume":"27","author":"Mainsiouw","year":"2023","journal-title":"J. Cell. Mol. Med."},{"issue":"1","key":"10.1016\/j.cmpb.2026.109293_bib0053","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1186\/s12885-023-10788-4","article-title":"KIF2C is a prognostic biomarker associated with immune cell infiltration in breast cancer","volume":"23","author":"Liu","year":"2023","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.cmpb.2026.109293_bib0054","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s13046-024-03101-z","article-title":"Shikonin blocks CAF-induced TNBC metastasis by suppressing mitochondrial biogenesis through GSK- 3\u03b2\/NEDD4-1 mediated phosphorylation-dependent degradation of PGC-1\u03b1","volume":"43","author":"Fan","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.cmpb.2026.109293_bib0055","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/s41594-022-00856-x","article-title":"Endocrine resistance and breast cancer plasticity are controlled by CoREST","volume":"29","author":"Garcia-Martinez","year":"2022","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"3","key":"10.1016\/j.cmpb.2026.109293_bib0056","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.neo.2014.03.008","article-title":"KIF14 promotes AKT phosphorylation and contributes to chemoresistance in triple-negative breast cancer","volume":"16","author":"Singel","year":"2014","journal-title":"Neoplasia"},{"issue":"10","key":"10.1016\/j.cmpb.2026.109293_bib0057","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1089\/dna.2020.5449","article-title":"Identification of SCARA5 gene as a potential immune-related biomarker for triple-negative breast cancer by integrated analysis","volume":"39","author":"Wang","year":"2020","journal-title":"DNA Cell Biol."},{"issue":"6","key":"10.1016\/j.cmpb.2026.109293_bib0058","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1016\/j.apsb.2023.03.009","article-title":"Hedgehog pathway orchestrates the interplay of histone modifications and tailors combination epigenetic therapies in breast cancer","volume":"13","author":"Wang","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.cmpb.2026.109293_bib0059","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-020-01580-6","article-title":"Long non-coding RNA MIR100HG promotes the migration, invasion and proliferation of triple-negative breast cancer cells by targeting the miR-5590-3p\/OTX1 axis","volume":"20","author":"Chen","year":"2020","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.cmpb.2026.109293_bib0060","article-title":"Multiomics analysis reveals CT83 is the most specific gene for triple negative breast cancer and its hypomethylation is oncogenic in breast cancer","volume":"11","author":"Chen","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cmpb.2026.109293_bib0061","article-title":"Investigating CENPW as a novel biomarker correlated with the development and poor prognosis of breast carcinoma","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Genet."},{"issue":"8","key":"10.1016\/j.cmpb.2026.109293_bib0062","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.3390\/cancers12082263","article-title":"Uptake transporters of the SLC21, SLC22A, and SLC15A families in anticancer therapy\u2014modulators of cellular entry or pharmacokinetics?","volume":"12","author":"Brecht","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.cmpb.2026.109293_bib0063","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.681946","article-title":"Prognostic biomarkers on a competitive endogenous RNA network reveals overall survival in triple-negative breast cancer","volume":"11","author":"Qin","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cmpb.2026.109293_bib0064","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s12282-021-01242-z","article-title":"Inhibition of Cdc20 suppresses the metastasis in triple negative breast cancer (TNBC)","volume":"28","author":"Song","year":"2021","journal-title":"Breast Cancer"},{"key":"10.1016\/j.cmpb.2026.109293_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12957-021-02200-x","article-title":"Overexpression of CCNE1 confers a poorer prognosis in triple-negative breast cancer identified by bioinformatic analysis","volume":"19","author":"Yuan","year":"2021","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.cmpb.2026.109293_bib0066","article-title":"Differentially expressed genes and key molecules of BRCA1\/2-mutant breast cancer: evidence from bioinformatics analyses","volume":"8","author":"Li","year":"2020","journal-title":"PeerJ"},{"key":"10.1016\/j.cmpb.2026.109293_bib0067","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2023.107867","article-title":"Peripheral blood mononuclear cell derived biomarker detection using explainable artificial intelligence (XAI) provides better diagnosis of breast cancer","volume":"104","author":"Kumar","year":"2023","journal-title":"Comput. Biol. Chem."},{"issue":"2","key":"10.1016\/j.cmpb.2026.109293_bib0068","first-page":"557","article-title":"Identification of key genes as potential biomarkers for triple-negative breast cancer using integrating genomics analysis","volume":"21","author":"Zhong","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.cmpb.2026.109293_bib0069","article-title":"Differential expression of RAD54-like in triple negative breast cancer","author":"Mamoor","year":"2021","journal-title":"OSF Preprints"},{"issue":"13","key":"10.1016\/j.cmpb.2026.109293_bib0071","doi-asserted-by":"crossref","first-page":"13991","DOI":"10.1002\/cam4.6040","article-title":"Characters of KRT80 and its roles in neoplasms diseases","volume":"12","author":"Wei","year":"2023","journal-title":"Cancer Med."},{"key":"10.1016\/j.cmpb.2026.109293_bib0072","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.681476","article-title":"Current triple-negative breast cancer subtypes: dissecting the most aggressive form of breast cancer","volume":"11","author":"Ensenyat-Mendez","year":"2021","journal-title":"Front. Oncol."},{"issue":"8","key":"10.1016\/j.cmpb.2026.109293_bib0073","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.7150\/jca.91753","article-title":"KRT80 promotes lung adenocarcinoma progression and serves as a substrate for VCP","volume":"15","author":"Huang","year":"2024","journal-title":"J. Cancer"},{"issue":"2","key":"10.1016\/j.cmpb.2026.109293_bib0074","doi-asserted-by":"crossref","first-page":"127","DOI":"10.22514\/ejgo.2024.034","article-title":"CDCA2 promotes breast cancer progression by downregulating KISS1 expression","volume":"45","author":"Luo","year":"2024","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"10.1016\/j.cmpb.2026.109293_bib0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117434","article-title":"Design, synthesis and optimization of apcin analogues as Cdc20 inhibitors for triple-negative breast cancer therapy","author":"Le","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cmpb.2026.109293_bib0076","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ebiom.2019.04.001","article-title":"Overexpression of PIMREG promotes breast cancer aggressiveness via constitutive activation of NF-\u03baB signaling","volume":"43","author":"Jiang","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.cmpb.2026.109293_bib0077","doi-asserted-by":"crossref","DOI":"10.1016\/j.devcel.2025.03.004","article-title":"KIF2C promotes paclitaxel resistance by depolymerizing polyglutamylated microtubules","author":"Pao","year":"2025","journal-title":"Dev. Cell"},{"issue":"9","key":"10.1016\/j.cmpb.2026.109293_bib0078","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.21037\/tcr-22-662","article-title":"Integrated bioinformatic analysis of potential biomarkers of poor prognosis in triple-negative breast cancer","volume":"11","author":"Bissanum","year":"2022","journal-title":"Transl. Cancer Res."}],"container-title":["Computer Methods and Programs in Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169260726000611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169260726000611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T18:28:36Z","timestamp":1774031316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169260726000611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":77,"alternative-id":["S0169260726000611"],"URL":"https:\/\/doi.org\/10.1016\/j.cmpb.2026.109293","relation":{},"ISSN":["0169-2607"],"issn-type":[{"value":"0169-2607","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Explainable machine learning framework for the molecular classification of triple negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"Computer Methods and Programs in Biomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmpb.2026.109293","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109293"}}